share_log

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%), etc.

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%), etc.

Janux Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%)等
美股sec公告 ·  08/09 16:13
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息